1. Home
  2. TH vs KALV Comparison

TH vs KALV Comparison

Compare TH & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$9.26

Market Cap

781.3M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.77

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
KALV
Founded
1978
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
781.3M
757.7M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
TH
KALV
Price
$9.26
$16.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$11.00
$30.00
AVG Volume (30 Days)
459.1K
797.5K
Earning Date
03-11-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,635,000.00
$50,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$5.94
$9.83
52 Week High
$9.90
$19.00

Technical Indicators

Market Signals
Indicator
TH
KALV
Relative Strength Index (RSI) 65.66 53.46
Support Level $7.80 $14.59
Resistance Level $9.90 $17.30
Average True Range (ATR) 0.41 1.11
MACD 0.07 -0.05
Stochastic Oscillator 72.20 46.54

Price Performance

Historical Comparison
TH
KALV

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: